APA (7th ed.) Citation

KM, L., Y, L., S, L., J, Z., B, B., G, Q., . . . SD, G. (2007). huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models. Cancer immunology, immunotherapy : CII, 56(4), 447. https://doi.org/10.1007/s00262-006-0203-1

Chicago Style (17th ed.) Citation

KM, Lo, Lan Y, Lauder S, Zhang J, Brunkhorst B, Qin G, Verma R, Courtenay-Luck N, and Gillies SD. "HuBC1-IL12, an Immunocytokine Which Targets EDB-containing Oncofetal Fibronectin in Tumors and Tumor Vasculature, Shows Potent Anti-tumor Activity in Human Tumor Models." Cancer Immunology, Immunotherapy : CII 56, no. 4 (2007): 447. https://doi.org/10.1007/s00262-006-0203-1.

MLA (9th ed.) Citation

KM, Lo, et al. "HuBC1-IL12, an Immunocytokine Which Targets EDB-containing Oncofetal Fibronectin in Tumors and Tumor Vasculature, Shows Potent Anti-tumor Activity in Human Tumor Models." Cancer Immunology, Immunotherapy : CII, vol. 56, no. 4, 2007, p. 447, https://doi.org/10.1007/s00262-006-0203-1.